Research Continues to Evolve Although the scientific literature surrounding GHK-Cu is promising, researchers continue to investigate optimal dosing, long-term outcomes, and the extent of its anti-aging effects
B., de Gaetano, G., Iacoviello, L., Gialluisi, A., & Izzi, B
Most large employer plans may cover Zepbound with prior authorization Most ACA marketplace and Medicare Part D plans exclude it for weight loss Coverage may still be possible through appeals or the OSA (sleep apnea) indication Best for: Employer plans, ACA marketplace, Medicare, Medicaid, TRICARE
Semaglutide is an FDA-approved medication originally developed to treat type 2 diabetes
Hepatic disease has been shown to reduce the clearance and prolong the half-life of many drugs
This observation has influenced how researchers design their retatrutide dosing protocols